Article
MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer.
The Journal of pathology - 1 Jul 2014
Liu Guoyan, Sun Yan, Ji Ping, Li Xia, Cogdell David, Yang Da, Parker Kerrigan Brittany C, Shmulevich Ilya, Chen Kexin, Sood Anil K, Xue Fengxia, Zhang Wei
Abstract excerpt
Ovarian carcinoma is the most lethal gynaecological malignancy. Better understanding of the molecular pathogenesis of this disease and effective targeted therapies are needed to improve patient outcomes. MicroRNAs play important roles in cancer progression and have the potential for use as either therapeutic agents or targets. Studies in other cancers have suggested that miR-506 has anti-tumour activity, but its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
